Top-News
Pharmazeutika USA

Phio Pharmaceuticals Inc Aktie

Aktie
WKN:  A40GMU ISIN:  US71880W5013 US-Symbol:  PHIO
1,8727 €
-0,3670 €
-16,52%
1,92 $ 16:29:14 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
126,67 Tsd.
Marktkapitalisierung *
344,73 Tsd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 05.07.2024

Phio Pharmaceuticals Inc News

10.11.22 - PR Newswire
Phio Pharmaceuticals Announces Study Results at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on November 10th and 11th
Phio Pharmaceuticals Announces Study Results at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on November 10th and 11th PR Newswire
06.10.22 - PR Newswire
Phio Pharmaceuticals Announces Upcoming Presentations at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Phio Pharmaceuticals Announces Upcoming Presentations at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) PR Newswire
29.09.22 - PR Newswire
Phio Pharmaceuticals Announces Appointment of Robert Bitterman as Executive Chairman
Phio Pharmaceuticals Announces Appointment of Robert Bitterman as Executive Chairman PR Newswire
22.09.22 - PR Newswire
Phio Pharmaceuticals Announces Preclinical Data Demonstrating PH-762 Enhances Persistence of T cells for Tumor Cell Killing as Presented by Helmholtz Munich at the 9th Immunotherapy of Cancer Conference
Phio Pharmaceuticals Announces Preclinical Data Demonstrating PH-762 Enhances Persistence of T cells for Tumor Cell Killing as Presented by Helmholtz Munich at the 9th ...
12.09.22 - PR Newswire
Phio Pharmaceuticals Announces Acceptance of Six Abstracts at The 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Phio Pharmaceuticals Announces Acceptance of Six Abstracts at The 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) PR Newswire
11.08.22 - PR Newswire
Phio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
Phio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update PR Newswire
06.06.22 - PR Newswire
Phio Pharmaceuticals Presents Study Outline of Its First Clinical Trial with PH-762 for Advanced Melanoma at the 2022 ASCO Annual Meeting
Phio Pharmaceuticals Presents Study Outline of Its First Clinical Trial with PH-762 for Advanced Melanoma at the 2022 ASCO Annual Meeting PR Newswire
16.05.22 - PR Newswire
Phio Pharmaceuticals Presents New Data Demonstrating PH-894 Enhances Activity of HER2-CAR-T Cells at ASGCT 2022
Phio Pharmaceuticals Presents New Data Demonstrating PH-894 Enhances Activity of HER2-CAR-T Cells at ASGCT 2022 PR Newswire
12.05.22 - PR Newswire
Phio Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
Phio Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update PR Newswire
05.05.22 - PR Newswire
Phio Pharmaceuticals Announces Senior Leadership Personnel Change
Phio Pharmaceuticals Announces Senior Leadership Personnel Change PR Newswire
03.05.22 - PR Newswire
Phio Pharmaceuticals Announces Trial-In-Progress Poster at ASCO 2022
Phio Pharmaceuticals Announces Trial-​In-Progress Poster at ASCO 2022 PR Newswire
02.05.22 - PR Newswire
Phio Pharmaceuticals Announces Upcoming Presentation of PH-894 Data at ASGCT 25th Annual Meeting 2022
Phio Pharmaceuticals Announces Upcoming Presentation of PH-894 Data at ASGCT 25th Annual Meeting 2022 PR Newswire
02.05.22 - PR Newswire
Phio Pharmaceuticals Announces the Appointment of Patricia A. Bradford to its Board of Directors
Phio Pharmaceuticals Announces the Appointment of Patricia A. Bradford to its Board of Directors PR Newswire
26.04.22 - PR Newswire
Phio Pharmaceuticals Announces the Start of its Phase 1b Clinical Trial of PH-762 for the Treatment of Advanced Melanoma
Phio Pharmaceuticals Announces the Start of its Phase 1b Clinical Trial of PH-762 for the Treatment of Advanced Melanoma PR Newswire
22.04.22 - PR Newswire
Thinking about buying stock in Indonesia Energy, Phio Pharmaceuticals, Redbox Entertainment, DiDi Global, or Cleveland-Cliffs?
Thinking about buying stock in Indonesia Energy, Phio Pharmaceuticals, Redbox Entertainment, DiDi Global, or Cleveland-​Cliffs? PR Newswire
18.04.22 - PR Newswire
Phio Pharmaceuticals Selected to Present at the Tumor Immune Microenvironment Workshop of the Society for Immunotherapy of Cancer
Phio Pharmaceuticals Selected to Present at the Tumor Immune Microenvironment Workshop of the Society for Immunotherapy of Cancer PR Newswire
13.04.22 - PR Newswire
Thinking about buying stock in Agile Therapeutics, Polarityte, Bed Bath & Beyond, Tellurian, or Phio Pharmaceuticals?
Thinking about buying stock in Agile Therapeutics, Polarityte, Bed Bath & Beyond, Tellurian, or Phio Pharmaceuticals? PR Newswire
11.04.22 - PR Newswire
Thinking about buying stock in Nio, Genocea Biosciences, Phio Pharmaceuticals, IQIYI, or Aterian?
Thinking about buying stock in Nio, Genocea Biosciences, Phio Pharmaceuticals, IQIYI, or Aterian? PR Newswire
08.04.22 - PR Newswire
Phio Pharmaceuticals Presents Positive New Data on PH-894 Demonstrating Antitumor Efficacy in Model of PD-1 Refractory Disease at the AACR Annual Meeting 2022
Phio Pharmaceuticals Presents Positive New Data on PH-894 Demonstrating Antitumor Efficacy in Model of PD-1 Refractory Disease at the AACR Annual Meeting 2022 PR Newswire
22.03.22 - PR Newswire
Phio Pharmaceuticals Reports 2021 Year End Financial Results and Provides Business Update
Phio Pharmaceuticals Reports 2021 Year End Financial Results and Provides Business Update PR Newswire

Newssuche

Videos

newspaper
31.12.24
Aktien: CRASH oder RALLYE in Q1?
Märkte bewegen sich aufgrund von fundamentalen Entwicklungen, nicht aufgrund von Linien im Chart oder ... Mehr »